Journal of Viral Hepatitis

Cover image for Vol. 15 Issue 5

May 2008

Volume 15, Issue 5

Pages 323–398

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver? (pages 323–330)

      J. T. Blackard and K. E. Sherman

      Version of Record online: 17 JAN 2008 | DOI: 10.1111/j.1365-2893.2008.00970.x

      • image
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. Hepatic inflammatory cytokine mRNA expression in hepatitis C virus–human immunodeficiency virus co-infection (pages 331–338)

      S. A. Gonzalez, C. Zhang, M. I. Fiel, S. Chung, L. Zhang, I. M. Jacobson and A. H. Talal

      Version of Record online: 20 DEC 2007 | DOI: 10.1111/j.1365-2893.2007.00949.x

      • image
      • image
      • image
    2. Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease (pages 339–345)

      M. R. B. Hamed, A. W. Tarr, C. P. McClure, J. K. Ball, T. P. Hickling and W. L. Irving

      Version of Record online: 22 JAN 2008 | DOI: 10.1111/j.1365-2893.2007.00947.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    3. Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2 (pages 346–356)

      A. J. Pérez-Berná, A. S. Veiga, M. A. R. B. Castanho and J. Villalaín

      Version of Record online: 21 DEC 2007 | DOI: 10.1111/j.1365-2893.2007.00948.x

      • image
      • image
      • image
      • image
      • image
    4. Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin (pages 363–369)

      M. Núñez, A. Ocampo, K. Aguirrebengoa, M. Cervantes, A. Pascual, S. Echeverria, V. Asensi, P. Barreiro, J. Garcia-Samaniego, V. Soriano and on behalf of the PRESCO Team

      Version of Record online: 21 DEC 2007 | DOI: 10.1111/j.1365-2893.2007.00952.x

      • image
    5. A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment (pages 370–378)

      Z. M. Younossi, F. H. Nader, C. Bai, R. Sjogren, J. P. Ong, R. Collantes, M. Sjogren, D. Farmer, L. Ramsey, K. Terra, H. Gujral, C. Gurung, M. Srishord and Y. Fang

      Version of Record online: 10 JAN 2008 | DOI: 10.1111/j.1365-2893.2007.00956.x

      • image
      • image
      • image
    6. Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5 (pages 383–386)

      N. Antaki, A. Hermes, M. Hadad, M. Ftayeh, F. Antaki, N. Abdo and K. Kebbewar

      Version of Record online: 13 DEC 2007 | DOI: 10.1111/j.1365-2893.2007.00946.x

    7. MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma (pages 387–391)

      L. Segat, A. Fabris, L. Padovan, M. Milanese, D. Pirulli, F. Lupo, M. Salizzoni, A. Amoroso and S. Crovella

      Version of Record online: 31 MAR 2008 | DOI: 10.1111/j.1365-2893.2008.00965.x

    8. Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B (pages 392–398)

      A. Gallego, J. Sheldon, J. García-Samaniego, N. Margall, M. Romero, P. Hornillos, V. Soriano and J. Enríquez

      Version of Record online: 31 MAR 2008 | DOI: 10.1111/j.1365-2893.2008.00966.x

      • image
      • image
      • image

SEARCH

SEARCH BY CITATION